Successful Collaborating

BioTeZ and the German Heart Institute Berlin developed a unique and reliable RNA-Binding Motif Protein 3 (RBM3) diagnostics tool box more ...

Companion Diagnostik Parkinson

New: 2016 Launch research project companion diagnostic Parkinson more….

Meet BioTeZ at MEDICA 2017, 13-16 November

Meet BioTeZ at MEDICA 2017 (13 – 16 Nov.)  and discuss themes in the field of Therapeutic Drug Monitoring, biochemistry components, affinity chromatography, human proteases, immobilization Technologies, upcoming research projects and more.

New: Monoclonal antibodies and biosimilars to fight diseases

Well tailored diagnostics recoveryELISA® to support drug development! Core of the diagnostics is the therapeutic antibody or biosimilar itself. The unique technology of recoveryELISA® enables to monitor simultaneous the full drug target interaction. more ...


Polystreptavidin R Coating Kit to functionalise surfaces, microfluidic Systems or Beads more ...

New Diagnostics

Infliximab Activity ELISA more…

New Diagnostics

Adalimumab Activity ELISA more...

New at BioTeZ

human proteases, ELISA protein assays and antibodies incl. the former Proteaimmun GmbH products and Services more ...

Innovationen bei Oligonukleotiden

Innovationen bei Oligonukleotiden auf dem VII. Nucleinsäurechemie-Treffen an der Humboldt-Universität zu Berlin unterstützt von BioTeZ am 17.-18. September 2015, Institut für Chemie, auf dem Campus Adlershof, Newtonstraße 14, 12489 Berlin, Walter-Nernst-Haus more ...

Our catalogue

Catalogue BioTeZ 2017
 complete Products and Services of BioTeZ download here ...

BioTeZ GmbH

Die BioTeZ Berlin-Buch GmbH ist ein Biotechnologie-Unternehmen und wurde 1992 gegründet. BioTeZ ist Partner der Forschung, der Pharmaindustrie und der Labordiagnostik.

  • Biodiagnostika
  • Oligonukleotide
  • Markierte Biomoleküle


BioTeZ Berlin Buch GmbH
Robert-Rössle-Strasse 10, Haus D 72
13125 Berlin - Germany

Tel: +49 30-9489-2130
Fax: +49 30-9494-509


Meet BioTeZ at MEDICA, 13-16 Nov. 2017, Düsseldorf. Get Information about diagnostics and biotechnological services we offer: Therapeutic Drug Monitoring, Mycotoxin and Vitamin Analysis, Oligonucleotides, Human Proteases Research, Streptavidin Coatings

Biologics and Biosimilars Congress 2017 BerlinBioTeZ will present the latest research results from collaboration projects at the 3rd Biologics and Biosimilars Congress (6-7 March 2017); Summarizing outcomes of therapeutic drug monitoring studies with Omalizumab/IgE, Adalimumab/TNF and provide insights into Alirocumab, Evolocumab/PCSK9 recoveryELISA projects